Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
 1 a 20 de 178 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Broekhuijsen K, van Baaren G-J, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KWM, Scheepers CJ, Bremer HA, Rijnders RJP, van Loon AJ, Perquin DAM, Sporken JMJ, Papatsonis DNM, van Huizen ME, Vredevoogd CB, Brons JTJ, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BWJ, Franssen MTM, Langenveld J, HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015;385:2492-501. [Ref.ID 99304]
2.Tiene citas relacionadas Cita con resumen
Trotta F, Da Cas R, Alegiani SS, Gramegna M, Venegoni M, Zocchetti C, Traversa G. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361. [Ref.ID 98028]
3.Tiene citas relacionadas
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1 influenza vaccination during pregnancy. BMJ 2014;348:g3500. [Ref.ID 98025]
4. Cita con resumen
Anónimo. Low-dose aspirin for prevention of preeclampsia. Med Lett Drugs Ther 2014;56:49. [Ref.ID 97920]
5. Cita con resumen
Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695-703. [Ref.ID 97613]
6.Tiene citas relacionadas Cita con resumen
Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013;346:10. [Ref.ID 95433]
7.Tiene citas relacionadas
Lucas R, Xiang F, Ponsonby A-L. Vitamin D sufficiency in pregnancy. BMJ 2013;346:7. [Ref.ID 95432]
8. Cita con resumen
Anónimo. Venlafaxine: prééclampsie et éclampsie. Prescrire 2012;32:352. [Ref.ID 92808]
9.Enlace a cita original Cita con resumen
Anónimo. Venlafaxine, pre-eclampsia, eclampsia and related disorders of pregnancy. Introduction. WHO Pharmaceuticals Newsletter 2012;1:19. [Ref.ID 92208]
10.Enlace a cita original
Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S, for the CHIPS Study Group. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011;72:394-401. [Ref.ID 90990]
11. Cita con resumen
Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011;342:d2901. [Ref.ID 90726]
12. Cita con resumen
Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Systematic Review 2011:7079. [Ref.ID 90506]
13.Tiene citas relacionadas
von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin FB, Côté A-M, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin J-M, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA, for the PIERS Study Group. Prediction of advese maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377:219-27. [Ref.ID 90076]
14.Tiene citas relacionadas
Teela KC, Ferguson RM, Donnay FA, Darmstadt GL. The PIERS trial: hope for averting deaths from pre-eclampsia. Lancet 2011;377:185-6. [Ref.ID 90075]
15.Enlace a cita original Cita con resumen
Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, on behal of the Guideline Development Group. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010;341:499-502. [Ref.ID 89344]
17.
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631-44. [Ref.ID 89175]
18.Tiene citas relacionadas Cita con resumen
McCance DR, Holmes VA, Maresh MJA, Patterson CC, Walker JD, Pearson DWM, Young IS, for the Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376:259-66. [Ref.ID 88923]
19.Tiene citas relacionadas
Sibai BM. Vitamin C and E to prevent pre-eclampsia in diabetic women. Lancet 2010;376:214-6. [Ref.ID 88916]
20. Cita con resumen
Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp Jr JM, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362:1282-91. [Ref.ID 88273]
Seleccionar todas
 
 1 a 20 de 178 siguiente >>